رجوع
53
61
نطاق اليوم
KWD 21.67
KWD 22.15
نطاق 52 أسبوعًا
KWD 16.52
KWD 25.15
حجم التداول
831,721
متوسط 50 يوم / 200 يوم
KWD 21.55
/
KWD 20.16
الإغلاق السابق
KWD 21.70
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (626 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | 5.2 | 0.4 |
| P/B | 1.2 | 2.9 |
| ROE % | 29.1 | 3.8 |
| Net Margin % | 63.8 | 3.9 |
| Rev Growth 5Y % | 2.1 | 10.0 |
| D/E | 0.2 | 0.2 |
النقاط الرئيسية
Revenue grew 2.06% annually over 5 years — modest growth
Earnings grew 1059.22% over the past year
ROE of 29.09% indicates high profitability
Net margin of 63.78% shows strong profitability
Debt/Equity of 0.23 — conservative balance sheet
Generating 195.80M in free cash flow
النمو
Revenue Growth (5Y)
2.06%
Revenue (1Y)18.52%
Earnings (1Y)1059.22%
FCF Growth (3Y)17.99%
الجودة
Return on Equity
29.09%
ROIC8.52%
Net Margin63.78%
Op. Margin38.52%
الأمان
Debt / Equity
0.23
Current Ratio14.64
Interest Coverage9.81
التقييم
P/E Ratio
5.20
P/B Ratio1.20
EV/EBITDA6.89
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 18.52% | Revenue Growth (3Y) | 17.02% |
| Earnings Growth (1Y) | 1059.22% | Earnings Growth (3Y) | 22.83% |
| Revenue Growth (5Y) | 2.06% | Earnings Growth (5Y) | 0.50% |
| Profitability | |||
| Revenue (TTM) | 425.13M | Net Income (TTM) | 271.17M |
| ROE | 29.09% | ROA | 16.58% |
| Gross Margin | 72.33% | Operating Margin | 38.52% |
| Net Margin | 63.78% | Free Cash Flow (TTM) | 195.80M |
| ROIC | 8.52% | FCF Growth (3Y) | 17.99% |
| Safety | |||
| Debt / Equity | 0.23 | Current Ratio | 14.64 |
| Interest Coverage | 9.81 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 5.20 | P/B Ratio | 1.20 |
| P/S Ratio | 3.32 | PEG Ratio | 0.01 |
| EV/EBITDA | 6.89 | Dividend Yield | 0.00% |
| Market Cap | 1.41B | Enterprise Value | 1.13B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 425.13M | 358.71M | 310.46M | 331.34M | 391.87M |
| Net Income | 271.17M | 23.39M | 179.72M | 213.92M | 265.85M |
| EPS (Diluted) | 3.30 | 0.36 | 2.20 | 2.37 | 2.87 |
| Gross Profit | 307.52M | 322.11M | 267.82M | 317.55M | 391.87M |
| Operating Income | 163.75M | 166.87M | 113.89M | -36.95M | 375.10M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1.64B | 1.30B | 1.24B | 1.23B | 926.40M |
| Total Liabilities | 462.32M | 609.90M | 568.55M | 665.71M | 400.46M |
| Shareholders' Equity | 1.17B | 691.16M | 674.96M | 565.79M | 414.74M |
| Total Debt | 269.02M | 451.10M | 449.08M | 544.07M | 394.76M |
| Cash & Equivalents | 550.94M | 304.96M | 193.51M | 291.05M | 201.53M |
| Current Assets | 727.52M | 554.31M | 344.22M | 443.51M | 313.67M |
| Current Liabilities | 49.70M | 236.08M | 38.13M | 134.97M | 5.81M |
درجات الاستراتيجيات
This stock passed the criteria for 2 strategies
Score = fit strength (0–100)
Rank = position among all matches
Custom
Capital Light Compounder
#46 of 213
#84 of 658
النشاط الأخير
دخل
Capital Light Compounder
Mar 24, 2026
دخل
Contrarian Investing (David Dreman)
Mar 24, 2026